HomeNewsDuterte defends purchase of Chinese COVID-19 vaccine

Duterte defends purchase of Chinese COVID-19 vaccine

The Philippines has locked in 25 million doses of China's Sinovac vaccine, with the first 50,000 expected to arrive in February

Philippine President Rodrigo Duterte defended his government’s decision to purchase Chinese-made coronavirus vaccines, saying they are as good as the shots developed by the Americans and the Europeans.

“The Chinese are not lacking in brains,” the president said in a late-night televised address on Wednesday, January 13. “The Chinese are bright. They would not venture (into producing vaccines) if it is not safe, sure and secure.”

Duterte made the remarks as questions have been raised over the level of protection Sinovac Biotech’s experimental COVID-19 vaccine can provide, after researchers in Brazil released late-stage clinical data showing efficacy that was lower than initially announced.

The president, however, said he would take responsibility if something should go wrong in the use of the vaccines. He said any vaccines procured by the government would “bind him.”

“It would be like I was the one who bought the vaccine. So I won’t buy a vaccine that’s not the right one,” he said, adding that “ultimately … if something goes wrong with what we in government choose and are negotiating for now, at the end of day, the responsibility is really mine.”

Senator Francis Pangilinan has earlier called on the government to cancel the purchase of the Sinovac vaccine, one of seven the Philippines is lining up as it plans to begin immunization next month.

The country has locked in 25 million doses of the Sinovac vaccine, with the first 50,000 expected to arrive in February.

- Newsletter -

Duterte, who has pursued warmer ties with Beijing, has expressed his preference to source COVID-19 vaccines from either China or Russia.

Carlito Galvez, a former military general in charge of the vaccination procurement effort, said the government has also firmed up supply deals with Novavax, Moderna, AstraZeneca, Pfizer, Johnson & Johnson, and Russia’s Gamaleya Institute for 137 million doses in total.

These are on top of 40 million doses the Philippines expects to receive through the World Health Organization’s COVAX facility in the first quarter, Galvez said.

The Philippines has among the most coronavirus cases in Asia but has trailed regional peers in securing vaccines, with which it hopes this year to inoculate 70 million people, or two-thirds of its population.

An opinion poll earlier showed that less than a third of Filipinos are willing to get inoculated against the coronavirus as many have voiced concerns over safety. Philippine regulators have yet to approve any COVID-19 vaccines. – with a report from Reuters

© Copyright LiCAS.news. All rights reserved. Republication of this article without express permission from LiCAS.news is strictly prohibited. For republication rights, please contact us at: [email protected]

Support LiCAS.news

We work tirelessly each day to tell the stories of those living on the fringe of society in Asia and how the Church in all its forms - be it lay, religious or priests - carries out its mission to support those in need, the neglected and the voiceless.
We need your help to continue our work each day. Make a difference and donate today.